0001739614-23-000002.txt : 20230103 0001739614-23-000002.hdr.sgml : 20230103 20230103180940 ACCESSION NUMBER: 0001739614-23-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deck Kelly CENTRAL INDEX KEY: 0001819427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39452 FILM NUMBER: 23503694 MAIL ADDRESS: STREET 1: C/O INHIBRX, INC. STREET 2: 11099 N. TORREY PINES ROAD, SUITE 280 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Inhibrx, Inc. CENTRAL INDEX KEY: 0001739614 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 824257312 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 795-4220 MAIL ADDRESS: STREET 1: 11025 N. TORREY PINES ROAD, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 wf-form4_167278735878222.xml FORM 4 X0306 4 2023-01-03 0 0001739614 Inhibrx, Inc. INBX 0001819427 Deck Kelly C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 23.3 2023-01-03 4 A 0 30000 0 A 2033-01-03 Common Stock 30000.0 30000 D Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on January 3, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter. /s/ Kelly D. Deck, attorney-in-fact 2023-01-03